Simplification of Complex Physiologically Based Pharmacokinetic Models of Monoclonal Antibodies

被引:0
|
作者
Mohamed Elmeliegy
Philip Lowe
Wojciech Krzyzanski
机构
[1] University at Buffalo—State University of New York,Department of Pharmaceutical Sciences, School of Pharmacy & Pharmaceutical Sciences
[2] Novartis Pharma AG,undefined
来源
The AAPS Journal | 2014年 / 16卷
关键词
compartmental models; monoclonal antibodies; PBPK;
D O I
暂无
中图分类号
学科分类号
摘要
Monoclonal antibodies (mAbs) exhibit biexponential profiles in plasma that are commonly described with a standard two-compartment model with elimination from the central compartment. These models adequately describe mAb plasma PK. However, these models ignore elimination from the peripheral compartment. This may lead to underestimation of the volume of distribution of the peripheral compartment and thus over-predicts concentration in the peripheral compartment. We developed a simple and physiologically relevant model that incorporates information on binding and dissociation rates between mAb and FcRn receptor, mAb uptake, reflection, and catabolic degradation. We employed a previously published PBPK model and, with assumptions regarding rates of processes controlling mAb disposition, reduced the complex PBPK model to a simpler circular model with central, peripheral, and lymph compartments specifying elimination from both central and peripheral. We successfully applied the model to describe the PK of an investigational mAb. Our model presents an improvement over standard two-compartmental models in predicting whole-body average tissue concentrations while adequately describing plasma PK with minimal complexity and physiologically more meaningful parameters.
引用
收藏
页码:810 / 842
页数:32
相关论文
共 50 条
  • [31] Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal Antibodies
    Shufang Liu
    Dhaval K. Shah
    The AAPS Journal, 25
  • [32] Incorporating target-mediated drug disposition in a minimal physiologically-based pharmacokinetic model for monoclonal antibodies
    Cao, Yanguang
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 (04) : 375 - 387
  • [33] Physiologically Based Pharmacokinetic Modeling to Characterize the Effect of Molecular Charge on Whole-Body Disposition of Monoclonal Antibodies
    Liu, Shufang
    Shah, Dhaval K.
    AAPS JOURNAL, 2023, 25 (03):
  • [34] Whole-body physiologically based pharmacokinetic models
    Nestorov, Ivan
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2007, 3 (02) : 235 - 249
  • [35] Physiologically based pharmacokinetic models for everolimus and sorafenib in mice
    Pawaskar, Dipti K.
    Straubinger, Robert M.
    Fetterly, Gerald J.
    Hylander, Bonnie H.
    Repasky, Elizabeth A.
    Ma, Wen W.
    Jusko, William J.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1219 - 1229
  • [36] Applications of minimal physiologically-based pharmacokinetic models
    Cao, Yanguang
    Jusko, William J.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2012, 39 (06) : 711 - 723
  • [37] INHALATION ANESTHESIA USING PHYSIOLOGICALLY BASED PHARMACOKINETIC MODELS
    FISEROVABERGEROVA, V
    DRUG METABOLISM REVIEWS, 1992, 24 (04) : 531 - 557
  • [38] The Link Between Pharmacodynamics and Physiologically Based Pharmacokinetic Models
    Perera, V.
    Elmeliegy, M. A.
    Rao, G.
    Forrest, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 (02) : 151 - 152
  • [39] Physiologically Based Pharmacokinetic Models of 2′,3′-Dideoxyinosine
    Hyo-Jeong K. Kang
    M. Guillaume Wientjes
    Jessie L.-S. Au
    Pharmaceutical Research, 1997, 14 : 337 - 344
  • [40] Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine
    Kang, HJK
    Wientjes, MG
    Au, JLS
    PHARMACEUTICAL RESEARCH, 1997, 14 (03) : 337 - 344